SECOND AMENDED AND RESTATED SENIOR SUBORDINATED CONVERTIBLE LOAN AGREEMENT originally dated as of December 31, 2018 and as amended and restated as of January 14, 2019 and February 22, 2019 by and among Melinta Therapeutics, Inc., as the Borrower, the...Senior Subordinated Convertible Loan Agreement • February 25th, 2019 • Melinta Therapeutics, Inc. /New/ • Pharmaceutical preparations • New York
Contract Type FiledFebruary 25th, 2019 Company Industry JurisdictionSECOND AMENDED AND RESTATED SENIOR SUBORDINATED CONVERTIBLE LOAN AGREEMENT (this “Agreement”), originally dated as of December 31, 2018 and as amended and restated as of January 14, 2019 and February 22, 2019, by and among Melinta Therapeutics, Inc., a Delaware corporation (the “Borrower”), the other Loan Parties (as defined below) party hereto from time to time and the lenders party hereto from time to time (together with their successors and permitted assigns, the “Lenders”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 25th, 2019 • Melinta Therapeutics, Inc. /New/ • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 25th, 2019 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into this 22 day of February 2019, by and between Melinta Therapeutics, Inc., a Delaware corporation (the “Company”), and John Johnson (“Executive”).